A Phase I Study Assessing the Safety, Tolerability, and Pharmacokinetics of Yinfenidone: A Novel, Potent Drug for Idiopathic Pulmonary Fibrosis Treatment in Healthy Chinese Subjects
A Phase I Study Assessing the Safety, Tolerability, and Pharmacokinetics of Yinfenidone: A Novel, Potent Drug for Idiopathic Pulmonary Fibrosis Treatment in Healthy Chinese Subjects. // Clinical Therapeutics. – URL: https://www.sciencedirect.com/science/article/pii/S014929182600189X?dgcid=rss_sd_all
A Phase I Study Assessing the Safety, Tolerability, and Pharmacokinetics of Yinfenidone: A Novel, Potent Drug for Idiopathic Pulmonary Fibrosis Treatment in Healthy Chinese Subjects. Clinical Therapeutics. https://www.sciencedirect.com/science/article/pii/S014929182600189X?dgcid=rss_sd_all
“A Phase I Study Assessing the Safety, Tolerability, and Pharmacokinetics of Yinfenidone: A Novel, Potent Drug for Idiopathic Pulmonary Fibrosis Treatment in Healthy Chinese Subjects.” Clinical Therapeutics.
@article{article41856,
title = {A Phase I Study Assessing the Safety, Tolerability, and Pharmacokinetics of Yinfenidone: A Novel, Potent Drug for Idiopathic Pulmonary Fibrosis Treatment in Healthy Chinese Subjects},
journal = {Clinical Therapeutics},
url = {https://www.sciencedirect.com/science/article/pii/S014929182600189X?dgcid=rss_sd_all}
}